The mortality rate for genitourinary system diseases in Canada is forecasted to decline slightly from 14.2 deaths per hundred thousand persons in 2024 to 13.6 in 2028. This indicates a consistent annual reduction. In 2023, the rate stood at 14.3. From 2024 to 2025, the rate decreases by approximately 1.4%, and the decline continues with annual reductions in the range of 0.7% to 1.4% over the proceeding years. The Compound Annual Growth Rate (CAGR) over the five years is expected to be -1.05%, signifying a gentle downward trend.
Future trends to watch for include advances in medical technology, improved healthcare policies, and increased public health awareness, which could further impact mortality rates. Monitoring changes in healthcare access and demographic shifts will be crucial for future analyses.
